Literature DB >> 16408282

Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.

Gülin Oz1, Melissa Terpstra, Ivan Tkác, Pratibha Aia, Jodi Lowary, Paul J Tuite, Rolf Gruetter.   

Abstract

Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra (SN), the cause of which is unknown. Characterization of early SN pathology could prove beneficial in the treatment and diagnosis of PD. The present study shows that with the use of short-echo (5 ms) Stimulated-Echo Acquisition Mode (STEAM) spectroscopy and LCModel, a neurochemical profile consisting of 10 metabolites, including gamma-aminobutyric acid (GABA), glutamate (Glu), and glutathione (GSH), can be measured from the unilateral SN at 4 tesla. The neurochemical profile of the SN is unique and characterized by a fourfold higher GABA/Glu ratio compared to the cortex, in excellent agreement with established neurochemistry. The presence of elevated GABA levels in SN was validated with the use of editing, suggesting that partial volume effects were greatly reduced. These findings establish the feasibility of obtaining a neurochemical profile of the unilateral human SN by single-voxel spectroscopy in small volumes. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16408282     DOI: 10.1002/mrm.20761

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  33 in total

Review 1.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

2.  Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.

Authors:  Isaac M Adanyeguh; Marie-Lorraine Monin; Daisy Rinaldi; Léorah Freeman; Alexandra Durr; Stéphane Lehéricy; Pierre-Gilles Henry; Fanny Mochel
Journal:  NMR Biomed       Date:  2018-01-09       Impact factor: 4.044

3.  Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.

Authors:  Adriane Gröger; Grzegorz Chadzynski; Jana Godau; Daniela Berg; Uwe Klose
Journal:  Eur Radiol       Date:  2011-04-12       Impact factor: 5.315

4.  Upper brainstem GABA levels in Parkinson's disease.

Authors:  Yulu Song; Tao Gong; Muhammad G Saleh; Mark Mikkelsen; Guangbin Wang; Richard A E Edden
Journal:  MAGMA       Date:  2021-03-20       Impact factor: 2.310

Review 5.  Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.

Authors:  Moonnoh R Lee; Aleksandar Denic; David J Hinton; Prasanna K Mishra; Doo-Sup Choi; Istvan Pirko; Moses Rodriguez; Slobodan I Macura
Journal:  Bioanalysis       Date:  2012-07       Impact factor: 2.681

Review 6.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

7.  Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications.

Authors:  N Agarwal; P F Renshaw
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-29       Impact factor: 3.825

8.  Simultaneous editing of GABA and glutathione at 7T using semi-LASER localization.

Authors:  Muhammad G Saleh; Mark Mikkelsen; Georg Oeltzschner; Kimberly L Chan; Adam Berrington; Peter B Barker; Richard A E Edden
Journal:  Magn Reson Med       Date:  2017-12-28       Impact factor: 4.668

9.  Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Authors:  Brian P Brennan; James I Hudson; J Eric Jensen; Julie McCarthy; Jacqueline L Roberts; Andrew P Prescot; Bruce M Cohen; Harrison G Pope; Perry F Renshaw; Dost Ongür
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

10.  Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.

Authors:  Meredith A Reid; Nina V Kraguljac; Kathy B Avsar; David M White; Jan A den Hollander; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2013-05-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.